Latest News from: American Society for Radiation Oncology (ASTRO)

Filters close
29-Mar-2021 8:05 PM EDT
COVID-19 pandemic has led to more advanced-stage cancer diagnoses, physician survey finds
American Society for Radiation Oncology (ASTRO)

Doctors who oversee cancer clinics say that new patients are arriving for treatment with more advanced disease than before the COVID-19 pandemic, according to a new survey from the American Society for Radiation Oncology (ASTRO). The survey fielded in early 2021 also found that treatment postponements and deferrals have largely subsided.

Released: 1-Mar-2021 10:40 AM EST
ASTRO applauds nominations of Chiquita Brooks-LaSure as CMS administrator and Elizabeth Fowler as CMMI director
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joseph R. Biden Jr.’s nomination of Chiquita Brooks-LaSure as administrator of the Centers for Medicare and Medicaid Services (CMS) and the appointment of Elizabeth Fowler as director of the Center for Medicare and Medicaid Innovation (CMMI).

Released: 22-Dec-2020 8:15 AM EST
Congressional leaders take action on RO Model to protect access to radiation oncology care
American Society for Radiation Oncology (ASTRO)

Congress passed legislation supported by the American Society for Radiation Oncology (ASTRO) that will delay the start of the Radiation Oncology Advanced Payment Model (RO Model) until Jan. 1, 2022, while bipartisan U.S. representatives sent an oversight letter to the Centers for Medicare and Medicaid Services (CMS) this week calling for changes to the flawed RO Model. In the letter led by Representatives Brian Higgins (D-N.Y.) and Mike Kelly (R-Penn.), 16 representatives urged CMS Administrator Seema Verma to protect cancer patients’ access to life-saving radiation treatments by scaling back deep reimbursement cuts for the nearly 1,000 radiation oncology providers required to participate in the model.

Newswise: Dr. Sue S. Yom named editor-in-chief of the International Journal of Radiation Oncology • Biology • Physics (Red Journal)
Released: 9-Dec-2020 6:05 PM EST
Dr. Sue S. Yom named editor-in-chief of the International Journal of Radiation Oncology • Biology • Physics (Red Journal)
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) announced today that Sue S. Yom, MD, PhD, FASTRO, will become the new editor-in-chief of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), ASTRO's flagship scientific journal. Dr. Yom will begin her five-year term on January 1, 2022.

Released: 7-Dec-2020 2:20 PM EST
ASTRO applauds nomination of Xavier Becerra as HHS secretary
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) today expressed its support for President-elect Joseph R. Biden Jr.’s nomination of Xavier Becerra as secretary of the Department of Health and Human Services (HHS).

Released: 18-Nov-2020 7:30 AM EST
Radiation oncologists urge Congress to advance bills that protect patient access to cancer care during the pandemic
American Society for Radiation Oncology (ASTRO)

Radiation oncologists across the country will meet virtually with members of Congress this week to urge lawmakers to pass legislation that will safeguard access to high-quality, value-based health care for people with cancer. The doctors will meet with Congressional leaders and staff as part of the American Society for Radiation Oncology (ASTRO) virtual Advocacy Day, which will take place November 19-20, 2020.

Released: 27-Oct-2020 6:05 PM EDT
Sexual Health Often Overlooked in Cancer Survivorship Care, Especially for Female Patients
American Society for Radiation Oncology (ASTRO)

A new study points to a need for oncologists to ask their patients about sexual health after chemotherapy, radiation and other cancer treatments. In a survey of nearly 400 cancer survivors, 87% said they experienced sexual side effects, but most also said their oncologist had not formally asked about them. Female patients were especially unlikely to be asked about sexual dysfunction. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released: 27-Oct-2020 5:05 PM EDT
Access to Radiation Therapy Has Grown, Especially in Densely Populated Areas
American Society for Radiation Oncology (ASTRO)

The number of radiation therapy facilities in the United States has grown by 17% over the last 15 years, according to a new study presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting. This growth has disproportionately favored urban areas already dense in treatment centers, however; roughly 5% of the U.S. population remains more than 50 miles from the closest facility.

Released: 27-Oct-2020 5:05 PM EDT
Study Finds Need for Better Inclusion of Patients From Racial Minority Groups in Radiation Therapy Trials
American Society for Radiation Oncology (ASTRO)

A new study finds that the racial composition of clinical trials involving radiation therapy does not match that of the U.S. population. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released: 26-Oct-2020 5:15 PM EDT
Adding image guidance to post-operative radiation therapy can reduce side effects for women with cervical cancer
American Society for Radiation Oncology (ASTRO)

A phase III trial from India shows that an advanced radiation therapy technique leads to fewer gastrointestinal side effects in women who receive radiation after undergoing hysterectomy for cervical cancer. Findings from the PARCER trial (NCT01279135) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

26-Oct-2020 8:40 AM EDT
Radiosurgery reduces cognitive decline without compromising survival for patients with 4+ brain metastases
American Society for Radiation Oncology (ASTRO)

Results of a new randomized phase III trial suggest that stereotactic radiosurgery (SRS) should replace whole brain radiation therapy (WBRT) as the standard of care for patients with four or more brain metastases. Results from the clinical trial (NCT01592968) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

26-Oct-2020 8:45 AM EDT
Treating spinal metastases with fewer and higher doses of radiation reduces pain more effectively
American Society for Radiation Oncology (ASTRO)

A new study shows using fewer and higher doses of high-precision radiation therapy is a more effective approach for treating painful spinal tumors than conventional radiation therapy. Findings from the Canadian phase II/III trial (NCT02512965) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

26-Oct-2020 8:50 AM EDT
Group trial bolsters case for stereotactic radiation therapy for tumors that travel to the lungs
American Society for Radiation Oncology (ASTRO)

A new study, conducted across 13 medical centers in Australia and New Zealand, strengthens the case for radiation therapy as a treatment for cancer that has begun to spread throughout the body. Findings of the SAFRON II trial (NCT01965223) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released: 26-Oct-2020 8:35 AM EDT
Adding advanced PET scans to radiation treatment plans for prostate cancer increases failure-free survival rates
American Society for Radiation Oncology (ASTRO)

Adding the advanced PET radiotracer fluciclovine to conventional imaging to help guide radiation treatments for recurrent prostate cancer can improve disease-free survival rates, a new study finds. Findings from the randomized phase II/III EMPIRE-1 trial (NCT01666808) will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released: 21-Oct-2020 8:30 AM EDT
ASTRO issues clinical guideline on radiation therapy for rectal cancer
American Society for Radiation Oncology (ASTRO)

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance for physicians who use radiation therapy to treat patients with locally advanced rectal cancer. Recommendations outline indications and best practices for pelvic radiation treatments, as well as the integration of radiation with chemotherapy and surgery for stage II-III disease. The guideline, which replaces ASTRO's 2016 guidance for rectal cancer, is published in Practical Radiation Oncology.

Released: 14-Oct-2020 8:00 AM EDT
Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) announced today the press program for its 2020 Annual Meeting, which will feature studies on cancer treatment advances and discussions of topical issues including COVID-19. Researchers will present their findings via live webcasts on October 26 and 27. Register for press access at www.astro.org/annnualmeetingpress.

Released: 1-Oct-2020 8:50 AM EDT
Benefits manager policy disrupts patient-physician decision making for breast and prostate cancer radiation treatments
American Society for Radiation Oncology (ASTRO)

Radiation oncologists today expressed serious concerns about a new private insurance coverage policy that could undermine patient-centered care for two of the most common cancers in the United States. Leaders of the American Society for Radiation Oncology (ASTRO) urge eviCore, a radiation oncology benefits management company, to halt and make meaningful changes to a new policy for radiation therapy coverage. Under the new policy, EviCore mandates that most breast and prostate cancer treatments use a shorter, hypofractionated radiation therapy regimen even if it runs counter to a physician’s clinical recommendation.

Released: 21-Sep-2020 9:50 AM EDT
ASTRO responds to CMS Radiation Oncology Model: Implementation delay and more reforms needed
American Society for Radiation Oncology (ASTRO)

In response to today’s announcement by the Centers for Medicare and Medicaid Services (CMS) to establish an advanced alternative payment model (APM) for radiation oncology practices starting January 1, 2021, the American Society for Radiation Oncology (ASTRO) issued the following statement from Theodore L. DeWeese, MD, FASTRO, Chair of the ASTRO Board of Directors.

Released: 23-Jul-2020 8:30 AM EDT
Leaders in radiation oncology awarded ASTRO Fellow designation
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) has selected 19 distinguished members to receive the ASTRO Fellow (FASTRO) designation. The 2020 class of Fellows will be recognized at a virtual awards ceremony on October 27 during ASTRO’s 62nd Annual Meeting.

Released: 22-Jul-2020 1:30 PM EDT
Dr. Geraldine Jacobson elected as future Chair of the American Society for Radiation Oncology (ASTRO)
American Society for Radiation Oncology (ASTRO)

The members of the American Society for Radiation Oncology (ASTRO) have elected four new officers to ASTRO’s Board of Directors. Geraldine Jacobson, MD, MPH, MBA, FASTRO, will begin her term as President-elect in October during ASTRO’s 62nd Annual Meeting.

Newswise: American Society for Radiation Oncology (ASTRO) to host virtual Annual Meeting, October 25-28
Released: 9-Jul-2020 1:00 PM EDT
American Society for Radiation Oncology (ASTRO) to host virtual Annual Meeting, October 25-28
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting, will be held October 25-28 via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center. Media resources are available at www.astro.org/astro2020press.

Released: 10-Jun-2020 7:50 AM EDT
ASTRO Issues First Clinical Guideline on Radiation Therapy for Cervical Cancer
American Society for Radiation Oncology (ASTRO)

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer. The guideline outlines indications and best practices for EBRT and brachytherapy in postoperative and definitive settings, and it also addresses chemotherapy and surgery when used in combination with radiation. The guideline is published online in Practical Radiation Oncology.

Released: 20-May-2020 8:00 AM EDT
ASTRO survey: Fewer patient visits despite enhanced COVID-19 safety measures for radiation oncology clinics
American Society for Radiation Oncology (ASTRO)

Despite facing challenges such as limited access to PPE during the COVID-19 outbreak, radiation oncology clinics quickly implemented safety enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO). All 222 physician leaders in the survey collected April 16-30 said their practices continued to provide radiation therapy, yet 85% also reported declines in patient visits, and by an average of one-third.

26-Feb-2020 12:15 PM EST
Drug used for breast, kidney cancers may also extend survival for patients with advanced head and neck cancer
American Society for Radiation Oncology (ASTRO)

A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment. Patients enrolled in a randomized phase II trial who received the mTOR inhibitor everolimus were more likely to be cancer-free a year after therapy than those who took a placebo drug, and the benefit persisted for those with mutations in their TP53 gene.

26-Feb-2020 8:20 AM EST
Radiation/immunotherapy combo shows promise for recurrent/metastatic head and neck cancers
American Society for Radiation Oncology (ASTRO)

A new phase II trial finds that a combination of radiation therapy and immunotherapy led to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and neck squamous cell carcinoma (HNSCC). The combination of radiation and pembrolizumab may offer a new treatment option for patients who are ineligible for cisplatin chemotherapy, part of standard treatment for the disease. Findings will be presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium.

26-Feb-2020 8:25 AM EST
Pre-operative immunotherapy triggers encouraging response in oral cancers
American Society for Radiation Oncology (ASTRO)

A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients. In the randomized trial, two neoadjuvant doses of nivolumab given with or without ipilimumab led to complete or partial tumor shrinkage in most cases and did not delay any patients from continuing on to standard treatment. Findings will be presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium.

Released: 19-Feb-2020 10:10 AM EST
H. Timothy Hsiao, Ph.D., joins the American Society for Radiation Oncology as Director of Scientific Affairs
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) recently welcomed H. Timothy Hsiao, Ph.D., as its new Director of Scientific Affairs, where he will provide strategic leadership to advance the impact of research and innovation in radiation oncology through ASTRO's research funding, fellowships, workshops and scientific collaborations with public and private partners.

Released: 13-Feb-2020 9:50 AM EST
ASTRO awarded contract from Department of Veterans Affairs to develop measures on quality of radiation therapy services
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) has been awarded a new one-year contract from the U.S. Department of Veterans Affairs (VA) to develop quality indicators (QI) for radiation treatments provided to veterans with head and neck, breast and gastrointestinal cancers.

Released: 22-Jan-2020 10:35 AM EST
Is it time to stop ringing the cancer bell?
American Society for Radiation Oncology (ASTRO)

A study published in the International Journal of Radiation Oncology • Biology • Physics finds that patients who celebrate the end of cancer treatment by ringing a bell report more distressful memories of treatment than those who finish without ringing a bell.

Newswise: Robert Amdur, MD, named Editor in Chief of Practical Radiation Oncology
Released: 15-Jan-2020 12:20 PM EST
Robert Amdur, MD, named Editor in Chief of Practical Radiation Oncology
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) announced today that Robert Amdur, MD, will become the new Editor in Chief of Practical Radiation Oncology, ASTRO's clinical practice journal. Dr. Amdur, a professor of radiation oncology at the University of Florida College of Medicine, will begin his five-year term on January 1, 2021.

Released: 8-Jan-2020 8:45 AM EST
Patient step counts predict lung cancer treatment outcomes, study finds
American Society for Radiation Oncology (ASTRO)

Numerous studies have shown that monitoring physical activity promotes better health – from reducing body mass index to watching for signs of hypertension, for example. A new study suggests step counters could play yet another role: predicting outcomes for people undergoing chemoradiation therapy for lung cancer.

Released: 12-Dec-2019 2:40 PM EST
ASTRO applauds Senate confirmation of Dr. Stephen Hahn as U.S. Food and Drug Administration Commissioner
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) applauded the U.S. Senate for voting today to confirm radiation oncologist Stephen Hahn, MD, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA).

Released: 10-Dec-2019 7:45 AM EST
ASTRO Issues New Clinical Guideline on Radiation Therapy for Basal and Squamous Cell Skin Cancers
American Society for Radiation Oncology (ASTRO)

A new clinical guideline from ASTRO provides recommendations on the use of radiation therapy to treat patients diagnosed with the most common types of skin cancers. The guideline details when radiation treatments are appropriate as stand-alone therapy or following surgery for BCC and cSCC, and it suggests dosing and fractionation.

Released: 3-Dec-2019 12:00 PM EST
ASTRO congratulates Dr. Stephen Hahn for securing Senate committee approval to lead U.S. Food and Drug Administration
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) expressed its support after the U.S. Senate Committee on Health, Education, Labor and Pensions voted today to approve the nomination of radiation oncologist Stephen Hahn, MD, FASTRO, as the next Commissioner of the Food and Drug Administration (FDA).

Newswise: Survey Finds 1 in 3 Patients Needed More Information on Cancer Treatment Side Effects
19-Nov-2019 2:50 PM EST
Survey Finds 1 in 3 Patients Needed More Information on Cancer Treatment Side Effects
American Society for Radiation Oncology (ASTRO)

One in three adults treated for cancer may experience side effects from treatment they wish they had known more about, according to a new survey published in the Journal of Oncology Practice. The national survey of more than 400 U.S. adults, which was sponsored by the American Society for Radiation Oncology (ASTRO), also found that nine in 10 patients felt they made the right treatment decision despite the desire for more information about treatment side effects.

Released: 13-Nov-2019 9:30 AM EST
Congressional leaders support radiation oncology community concerns about proposed Medicare alternative payment model
American Society for Radiation Oncology (ASTRO)

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model). CMS is expected to issue its final determination before the end of 2019.

Released: 1-Nov-2019 2:50 PM EDT
ASTRO supports nomination of Dr. Stephen Hahn to lead U.S. Food and Drug Administration
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) today expressed strong support for the nomination of radiation oncologist Stephen Hahn, MD, FASTRO, as Commissioner of the Food and Drug Administration (FDA). Dr. Hahn served on the ASTRO Board of Directors from 2014 to 2018.

Released: 30-Oct-2019 8:35 AM EDT
New research suggests proton radiation therapy can benefit patients with challenging liver tumors
American Society for Radiation Oncology (ASTRO)

Two new studies support and inform the use of proton radiation therapy to treat patients with hepatocellular carcinoma (HCC), a common but often fatal type of liver cancer for which there are limited treatment options. The studies were published in the International Journal of Radiation Oncology • Biology • Physics, the flagship scientific journal of the American Society for Radiation Oncology (ASTRO).

Released: 22-Oct-2019 1:55 PM EDT
ASTRO and ACR update practice parameters for radiation therapy treatments
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) and the American College of Radiology (ACR) recently released seven updated practice parameters for medical providers who use radiation therapy to treat patients with cancer. The updated practice parameters synthesize the clinical best practices that describe recommended procedures and considerations for the safe delivery of radiation in specific areas of clinical practice.

Newswise: ASTRO honors 2019 Gold Medalists, Honorary Member and other award recipients
Released: 2-Oct-2019 12:05 PM EDT
ASTRO honors 2019 Gold Medalists, Honorary Member and other award recipients
American Society for Radiation Oncology (ASTRO)

The American Society for Radiation Oncology (ASTRO) recognized the recipients of its 2019 Gold Medal awards and other high-profile honors at the 61st ASTRO Annual Meeting in Chicago. View/download photos from the September 17 awards ceremony online.

Released: 26-Sep-2019 11:05 AM EDT
Noninvasive radiation treatment offers long-term benefits to patients with high-risk heart arrhythmias
American Society for Radiation Oncology (ASTRO)

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 11:05 AM EDT
PACIFIC survival rates explained: Lung cancer spread reduced, new distant growth most often in the brain
American Society for Radiation Oncology (ASTRO)

A new analysis of survival data for the randomized, phase III PACIFIC trial finds adding the immunotherapy cancer drug durvalumab to radiation and chemotherapy significantly decreased the recurrence of lung cancer both in the chest area and in distant sites outside the chest. The update, which provides greater insight into the landmark study that changed the standard of care for patients with stage 3 unresectable non-small-cell lung cancer (NSCLC), were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 11:05 AM EDT
Trial reports randomized evidence high-dose radiation is effective for men whose prostate cancer has spread
American Society for Radiation Oncology (ASTRO)

A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 11:05 AM EDT
Women equally satisfied with cosmetic results of both partial and whole breast radiation therapy after lumpectomy
American Society for Radiation Oncology (ASTRO)

Whole breast radiation and partial breast radiation following a lumpectomy yield similar cosmetic outcomes for women diagnosed with early stages of cancer who wish to preserve their breasts. Findings of the new analysis from a phase III clinical trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 11:05 AM EDT
Adding radiation after immunotherapy improves progression-free survival for some patients with metastatic lung cancer
American Society for Radiation Oncology (ASTRO)

Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer (NSCLC), increasing progression-free survival (PFS). Findings of the phase II randomized trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 11:05 AM EDT
Women’s health clinics closures associated with higher cervical cancer mortality and lower screening rates
American Society for Radiation Oncology (ASTRO)

Following the closure of nearly 100 women’s health clinics across the United States from 2010 to 2013, fewer women were screened for cervical cancer, more women were diagnosed with advanced stages of the disease and mortality rates rose. Findings from a new analysis combining several nationwide datasets were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 11:05 AM EDT
Artificial Intelligence accurately predicts radiation treatment side effects for patients with head and neck cancers
American Society for Radiation Oncology (ASTRO)

For the first time, a sophisticated computer model has been shown to accurately predict two of the most challenging side effects associated with radiation therapy for head and neck cancer. This precision oncology approach has the potential to better identify patients who might benefit from early interventions that may help to prevent significant weight loss after treatment or reduce the need for feeding tube placement. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 26-Sep-2019 10:05 AM EDT
Long-term hormone therapy increases mortality risk for men with low PSA levels after prostate surgery
American Society for Radiation Oncology (ASTRO)

A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient’s post-operative prostate-specific antigen (PSA) level. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO).

Released: 17-Sep-2019 3:05 AM EDT
ASTRO comments to the Centers for Medicare and Medicaid Services regarding their proposed radiation oncology alternative payment model
American Society for Radiation Oncology (ASTRO)

In response to the Centers for Medicare and Medicaid Services' (CMS) request for comment on their proposed advanced alternative payment model (APM) for radiation oncology, the American Society for Radiation Oncology (ASTRO) submitted comments and issued the following statement today from Paul Harari, MD, FASTRO, Chair of the ASTRO Board of Directors.


Showing results

150 of 731

close
0.33942